Cigna Group (CI) Faces A Valuation Test, Is The Recent Pullback A Buying Opportunity?
Why Cigna (CI) Stock Is Up Today
What to Expect From Cigna's Next Quarterly Earnings Report
Bernstein Maintains Outperform on Cigna Group, Raises Price Target to $381
The Cigna Group's Second Quarter 2026 Earnings Release Details
Cigna (CI) Stock Just Lost Its Place In Key Russell Growth Indexes
Cigna (CI) Stock Still Looks Cheap As Earnings Stay Strong
What Cigna Group (CI)'s US$100 Million Pharmacy Forward AI Bet Means For Shareholders
Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions
The Cigna Group Foundation Honors David M. Cordani's Leadership with New Grant to Strengthen Military Communities
Winners And Losers Of Q1: Cigna (NYSE:CI) Vs The Rest Of The Health Insurance Providers Stocks
The Cigna Group Foundation Invests $3 Million to Strengthen Youth Mental Health Through Nonprofits Across 10 States
Cigna's Philanthropic Arm Invests $3M In Grants To 22 Nonprofits
Cigna (CI): Buy, Sell, or Hold Post Q1 Earnings?
Options Action: A stable, cash-generating stock to counter the volatility
Mizuho Sees Improved Regulatory Stability, Raises Cigna (CI) Price Objective
Mizuho Maintains Outperform on Cigna Group, Raises Price Target to $340
Cigna Grant Focus On Veteran Mental Health Links To Valuation Debate
The Cigna Group Foundation Launches 2026 Grant Program to Support Veterans
'Cigna drops coverage of GLP-1 obesity drugs for its own employees'- Reuters Exclusive
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.